This was the stock's sixth consecutive day of losses.
Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...
Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...
The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for ...
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Labcorp Holdings (LH – Research Report), with a ...
Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...
Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...